Skip to main content
SpringerLink
Log in

LL-37: An Immunomodulatory Antimicrobial Host Defence Peptide

  • Chapter
  • First Online:
Antimicrobial Peptides and Innate Immunity

Part of the book series: Progress in Inflammation Research ((PIR))

Abstract

Cationic host defence peptides (CHDP) are conserved peptide components of the innate immune system. These peptides, also known as antimicrobial peptides, were originally discovered and described on the basis of their direct microbicidal properties. However, it has become increasingly clear that CHDP, such as the human cathelicidin hCAP18/LL-37, have an extensive range of immunomodulatory properties that can be complementary to microbicidal activity or may even represent their major antimicrobial function. As a result of its capacity to interact with cells involved in host defence LL-37 can modulate both innate inflammatory processes and interact with the generation of adaptive immunity. CHDP have been implicated in a variety of disease processes at diverse organ sites and are attracting increasing attention as templates for the development of novel immunomodulatory antimicrobial therapeutics. This chapter will focus on the antimicrobial and immunomodulatory properties of hCAP18/LL-37 and the underlying mechanisms involved in the bioactivity of this peptide.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aarbiou J, Tjabringa GS, Verhoosel RM, Ninaber DK, White SR, Peltenburg LT, Rabe KF, Hiemstra PS (2006) Mechanisms of cell death induced by the neutrophil antimicrobial peptides alpha-defensins and LL-37. Inflamm Res 55:119–127

    Article  PubMed  CAS  Google Scholar 

  • Alalwani MS, Sierigk J, Herr C, Pinkenburg O, Gallo R, Vogelmeier C, Bals R (2010) The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Eur J Immunol 40:1118–1126

    Article  PubMed  CAS  Google Scholar 

  • An LL, Yang YH, Ma XT, Lin YM, Li G, Song YH, Wu KF (2005) LL-37 enhances adaptive antitumor immune response in a murine model when genetically fused with M-CSFR(J6-1) DNA vaccine. Leuk Res 29:535–543

    Article  PubMed  CAS  Google Scholar 

  • Anderson RL, Hiemstra PS, Ward C, Forrest IA, Murphy D, Proud D, Lordan J, Corris PA, Fisher AJ (2008) Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Eur Respir J 32:670–677

    Article  PubMed  CAS  Google Scholar 

  • Bals R, Weiner DJ, Moscioni AD, Meegalla RL, Wilson JM (1999) Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun 67:6084–6089

    PubMed  CAS  Google Scholar 

  • Bandholtz L, Ekman GJ, Vilhelmsson M, Buentke E, Agerberth B, Scheynius A, Gudmundsson GH (2006) Antimicrobial peptide LL-37 internalized by immature human dendritic cells alters their phenotype. Scand J Immunol 63:410–419

    Article  PubMed  CAS  Google Scholar 

  • Barlow PG, Li Y, Wilkinson TS, Bowdish DM, Lau YE, Cosseau C, Haslett C, Simpson AJ, Hancock RE, Davidson DJ (2006) The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J Leukoc Biol 80:509–520

    Article  PubMed  CAS  Google Scholar 

  • Barlow PG, Beaumont PE, Cosseau C, Mackellar A, Wilkinson TS, Hancock RE, Haslett C, Govan JRW, Simpson AJ, Davidson DJ (2010) The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. Am J Respir Cell Mol Biol 43:692–702

    Article  PubMed  CAS  Google Scholar 

  • Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, Davidson DJ, Donis RO (2011) Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One 6:e25333

    Article  PubMed  CAS  Google Scholar 

  • Bergman P, Walter-Jallow L, Broliden K, Agerberth B, Soderlund J (2007) The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res 5:410–415

    Article  PubMed  CAS  Google Scholar 

  • Bianchi SM, Dockrell DH, Renshaw SA, Sabroe I, Whyte MK (2006) Granulocyte apoptosis in the pathogenesis and resolution of lung disease. Clin Sci (Lond) 110:293–304

    Article  CAS  Google Scholar 

  • Bjorstad A, Askarieh G, Brown KL, Christenson K, Forsman H, Onnheim K, Li HN, Teneberg S, Maier O, Hoekstra D, Dahlgren C, Davidson DJ, Bylund J (2009) The host defence peptide Ll-37 selectively permeabilises apoptotic leukocytes. Antimicrob Agents Chemother 53:1027–1038

    Article  PubMed  CAS  Google Scholar 

  • Bowdish DME, Davidson DJ, Speert DP, Hancock REW (2004) The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J Immunol 172:3758–3765

    PubMed  CAS  Google Scholar 

  • Bowdish DME, Davidson DJ, Hancock REW (2005a) A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci 6:35–51

    Article  PubMed  CAS  Google Scholar 

  • Bowdish DME, Davidson DJ, Lau YE, Lee K, Scott MG, Hancock REW (2005b) Impact of LL-37 on anti-infective immunity. J Leukoc Biol 77:451–459

    Article  PubMed  CAS  Google Scholar 

  • Bowdish DME, Davidson DJ, Hancock REW (2006) Immunomodulatory properties of defensins and cathelicidins. Curr Top Microbiol Immunol 306:27–66

    Article  PubMed  CAS  Google Scholar 

  • Braff MH, Hawkins MA, Nardo AD, Lopez-Garcia B, Howell MD, Wong C, Lin K, Streib JE, Dorschner R, Leung DY, Gallo RL (2005) Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol 174:4271–4278

    PubMed  CAS  Google Scholar 

  • Bucki R, Byfield FJ, Janmey PA (2007) Release of the antimicrobial LL37 peptide from DNA/F-actin bundles in CF sputum. Eur Respir J 29:624–632

    Article  PubMed  CAS  Google Scholar 

  • Burton MF, Steel PG (2009) The chemistry and biology of LL-37. Nat Prod Rep 26:1572–1584

    Article  PubMed  CAS  Google Scholar 

  • Byfield FJ, Kowalski M, Cruz K, Leszczynska K, Namiot A, Savage PB, Bucki R, Janmey PA (2011a) Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa. J Immunol 187:6402–6409

    Article  PubMed  CAS  Google Scholar 

  • Byfield FJ, Wen Q, Leszczynska K, Kulakowska A, Namiot Z, Janmey PA, Bucki R (2011b) Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability. Am J Physiol Cell Physiol 300:C105–C112

    Article  PubMed  CAS  Google Scholar 

  • Carretero M, Escamez MJ, Garcia M, Duarte B, Holguin A, Retamosa L, Jorcano JL, Rio MD, Larcher F (2008) In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J Invest Dermatol 128:223–236

    Article  PubMed  CAS  Google Scholar 

  • Chamorro CI, Weber G, Gronberg A, Pivarcsi A, Stahle M (2009) The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. J Invest Dermatol 129:937–944

    Article  PubMed  CAS  Google Scholar 

  • Chen CI, Schaller-Bals S, Paul KP, Wahn U, Bals R (2004) Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J Cyst Fibros 3:45–50

    Article  PubMed  CAS  Google Scholar 

  • Chen X, Niyonsaba F, Ushio H, Okuda D, Nagaoka I, Ikeda S, Okumura K, Ogawa H (2005) Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J Dermatol Sci 40:123–132

    Article  PubMed  CAS  Google Scholar 

  • Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, Ehren I, Hokfelt T, Gudmundsson GH, Gallo RL, Agerberth B, Brauner A (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12:636–641

    Article  PubMed  CAS  Google Scholar 

  • Cirioni O, Giacometti A, Ghiselli R, Bergnach C, Orlando F, Silvestri C, Mocchegiani F, Licci A, Skerlavaj B, Rocchi M, Saba V, Zanetti M, Scalise G (2006) LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother 50:1672–1679

    Article  PubMed  CAS  Google Scholar 

  • Cirioni O, Ghiselli R, Tomasinsig L, Orlando F, Silvestri C, Skerlavaj B, Riva A, Rocchi M, Saba V, Zanetti M, Scalise G, Giacometti A (2008) Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas Aeruginosa. Shock 30:443–448

    Article  PubMed  CAS  Google Scholar 

  • Coffelt SB, Waterman RS, Florez L, Bentrup KH, Zwezdaryk KJ, Tomchuck SL, Lamarca HL, Danka ES, Morris CA, Scandurro AB (2008) Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion. Int J Cancer 122(5):1030–9

    Article  PubMed  CAS  Google Scholar 

  • Coffelt SB, Marini FC, Watson K, Zwezdaryk KJ, Dembinski JL, LaMarca HL, Tomchuck SL, Honer zu Bentrup K, Danka ES, Henkle SL, Scandurro AB (2009a) The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc Natl Acad Sci USA 106:3806–3811

    Article  PubMed  Google Scholar 

  • Coffelt SB, Tomchuck SL, Zwezdaryk KJ, Danka ES, Scandurro AB (2009b) Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells. Mol Cancer Res 7:907–915

    Article  PubMed  CAS  Google Scholar 

  • Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC, Hancock RE, Speert DP (2004) The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 172:1146–1156

    PubMed  CAS  Google Scholar 

  • den Hertog AL, van Marle J, van Veen HA, Van’t Hof W, Bolscher JG, Veerman EC, Nieuw Amerongen AV (2005) Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem J 388:689–695

    Article  CAS  Google Scholar 

  • Doring Y, Drechsler M, Wantha S, Kemmerich K, Lievens D, Vijayan S, Gallo RL, Weber C, Soehnlein O (2012) Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ Res 110(8):1052–6

    Article  PubMed  CAS  Google Scholar 

  • Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, Agerberth B, Gudmundsson GH, Gallo RL (2001) Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117:91–97

    Article  PubMed  CAS  Google Scholar 

  • Dorschner RA, Lopez-Garcia B, Peschel A, Kraus D, Morikawa K, Nizet V, Gallo RL (2006) The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J 20:35–42

    Article  PubMed  CAS  Google Scholar 

  • Elssner A, Duncan M, Gavrilin M, Wewers MD (2004) A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol 172:4987–4994

    PubMed  CAS  Google Scholar 

  • Erdag G, Morgan JR (2002) Interleukin-1alpha and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts. Ann Surg 235:113–124

    Article  PubMed  Google Scholar 

  • Filewod NC, Pistolic J, Hancock RE (2009) Low concentrations of LL-37 alter IL-8 production by keratinocytes and bronchial epithelial cells in response to proinflammatory stimuli. FEMS Immunol Med Microbiol 56:233–240

    Article  PubMed  CAS  Google Scholar 

  • Frohm M, Agerberth B, Ahangari G, Stahle-Backdahl M, Liden S, Wigzell H, Gudmundsson GH (1997) The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 272:15258–15263

    Article  PubMed  CAS  Google Scholar 

  • Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchinetti V, Homey B, Barrat FJ, Zal T, Gilliet M (2009) Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 206:1983–1994

    Article  PubMed  CAS  Google Scholar 

  • Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3:73ra20

    Article  PubMed  Google Scholar 

  • Girnita A, Zheng H, Gronberg A, Girnita L, Stahle M (2011) Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor. Oncogene 31:352–365

    Article  PubMed  CAS  Google Scholar 

  • Gombart AF, Borregaard N, Koeffler HP (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 19:1067–1077

    Article  PubMed  CAS  Google Scholar 

  • Grassme H, Kirschnek S, Riethmueller J, Riehle A, von Kurthy G, Lang F, Weller M, Gulbins E (2000) CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. Science 290:527–530

    Article  PubMed  CAS  Google Scholar 

  • Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R (1996) The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 238:325–332

    Article  PubMed  CAS  Google Scholar 

  • Hancock RE, Rozek A (2002) Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett 206:143–149

    Article  PubMed  CAS  Google Scholar 

  • Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW (2008) Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 181:7090–7099

    PubMed  CAS  Google Scholar 

  • Hasan M, Ruksznis C, Wang Y, Leifer CA (2011) Antimicrobial peptides inhibit polyinosinic-polycytidylic acid-induced immune responses. J Immunol 187:5653–5659

    Article  PubMed  CAS  Google Scholar 

  • Heilborn JD, Nilsson MF, Kratz G, Weber G, Sorensen O, Borregaard N, Stahle-Backdahl M (2003) The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 120:379–389

    Article  PubMed  CAS  Google Scholar 

  • Heilborn JD, Nilsson MF, Jimenez CI, Sandstedt B, Borregaard N, Tham E, Sorensen OE, Weber G, Stahle M (2005) Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Int J Cancer 114:713–719

    Article  PubMed  CAS  Google Scholar 

  • Henzler Wildman KA, Lee DK, Ramamoorthy A (2003) Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry 42:6545–6558

    Article  PubMed  CAS  Google Scholar 

  • Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, Leung DY (2004) Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol 172:1763–1767

    PubMed  CAS  Google Scholar 

  • Huang LC, Reins RY, Gallo RL, McDermott AM (2007) Cathelicidin-deficient (Cnlp -/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 48:4498–4508

    Article  PubMed  Google Scholar 

  • Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, Kagnoff MF (2005) Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol 174:4901–4907

    PubMed  CAS  Google Scholar 

  • Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B, Gudmundsson G (2001) Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 7:180–185

    Article  PubMed  CAS  Google Scholar 

  • Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B (1998) Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273:3718–3724

    Article  PubMed  CAS  Google Scholar 

  • Jones A, Georg Lisa M, Maudsdotter L, Jonsson AB (2009) Endotoxin, capsule and bacterial attachment contribute to Neisseria meningitidis resistance to the human antimicrobial peptide, LL-37. J Bacteriol 191:3861–3868

    Article  PubMed  CAS  Google Scholar 

  • Kandler K, Shaykhiev R, Kleemann P, Klescz F, Lohoff M, Vogelmeier C, Bals R (2006) The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int Immunol 18:1729–1736

    Article  PubMed  CAS  Google Scholar 

  • Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373–384

    Article  PubMed  CAS  Google Scholar 

  • Kida Y, Shimizu T, Kuwano K (2006) Sodium butyrate up-regulates cathelicidin gene expression via activator protein-1 and histone acetylation at the promoter region in a human lung epithelial cell line, EBC-1. Mol Immunol 43:1972–1981

    Article  PubMed  CAS  Google Scholar 

  • Koczulla R, Von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, Issbrucker K, Unterberger P, Zaiou M, Lebherz C, Karl A, Raake P, Pfosser A, Boekstegers P, Welsch U, Hiemstra PS, Vogelmeier C, Gallo RL, Clauss M, Bals R (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111:1665–1672

    PubMed  CAS  Google Scholar 

  • Koon HW, Shih DQ, Chen J, Bakirtzi K, Hing TC, Law I, Ho S, Ichikawa R, Zhao D, Xu H, Gallo R, Dempsey P, Cheng G, Targan SR, Pothoulakis C (2011) Cathelicidin signaling via the Toll-like receptor protects against colitis in mice. Gastroenterology 141:1852–1863

    Article  PubMed  CAS  Google Scholar 

  • Kurosaka K, Chen Q, Yarovinsky F, Oppenheim JJ, Yang D (2005) Mouse cathelin-related antimicrobial Peptide chemoattracts leukocytes using formyl Peptide receptor-like 1/mouse formyl Peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J Immunol 174:6257–6265

    PubMed  CAS  Google Scholar 

  • Lai Y, Gallo RL (2009) AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30:131–141

    Article  PubMed  CAS  Google Scholar 

  • Lai Y, Adhikarakunnathu S, Bhardwaj K, Ranjith-Kumar CT, Wen Y, Jordan JL, Wu LH, Dragnea B, Mateo LS, Kao CC (2011) LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs. PLoS One 6:e26632

    Article  PubMed  CAS  Google Scholar 

  • Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, Cao W, Wang YH, Su B, Nestle FO, Zal T, Mellman I, Schroder JM, Liu YJ, Gilliet M (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449:564–569

    Article  PubMed  CAS  Google Scholar 

  • Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, Meller S, Chamilos G, Sebasigari R, Riccieri V, Bassett R, Amuro H, Fukuhara S, Ito T, Liu YJ, Gilliet M (2011) Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3:73ra19

    Article  PubMed  Google Scholar 

  • Lau YE, Rozek A, Scott MG, Goosney DL, Davidson DJ, Hancock REW (2005) Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect Immun 73:583–591

    Article  PubMed  CAS  Google Scholar 

  • Lau YE, Bowdish DME, Cosseau CC, Hancock REW, Davidson DJ (2006) Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37. Am J Respir Cell Mol Biol 34:399–409

    Article  PubMed  CAS  Google Scholar 

  • Leszczynska K, Namiot A, Janmey PA, Bucki R (2010) Modulation of exogenous antibiotic activity by host cathelicidin LL-37. APMIS 118:830–836

    Article  PubMed  CAS  Google Scholar 

  • Li X, Li Y, Han H, Miller DW, Wang G (2006) Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J Am Chem Soc 128:5776–5785

    Article  PubMed  CAS  Google Scholar 

  • Li HN, Barlow PG, Bylund J, Mackellar A, Bjorstad A, Conlon J, Hiemstra PS, Haslett C, Gray M, Simpson AJ, Rossi AG, Davidson DJ (2009) Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages. J Leukoc Biol 86:891–902

    Article  PubMed  CAS  Google Scholar 

  • Lipsky BA, Holroyd KJ, Zasloff M (2008) Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin Infect Dis 47:1537–1545

    Article  PubMed  Google Scholar 

  • Lister MF, Sharkey J, Sawatzky DA, Hodgkiss JP, Davidson DJ, Rossi AG, Finlayson K (2007) The role of the purinergic P2X7 receptor in inflammation. J Inflamm (Lond) 4:5

    Article  CAS  Google Scholar 

  • Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770–1773

    Article  PubMed  CAS  Google Scholar 

  • Logermann S, Gwyer Findlay E, Mackellar A, Tian M, Wang H, Fitch P, Schwarze JS, Davidson DJ (2012) The human cathelicidin LL-37 has potent antiviral activity against Respiratory Syncytial Virus (under revision)

    Google Scholar 

  • Mader JS, Mookherjee N, Hancock RE, Bleackley RC (2009) The human host defense peptide LL-37 induces apoptosis in a calpain- and apoptosis-inducing factor-dependent manner involving Bax activity. Mol Cancer Res 7:689–702

    Article  PubMed  CAS  Google Scholar 

  • Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, Skolimowska K, Davidson RN, Sorensen OE, Kampmann B, Griffiths CJ, Wilkinson RJ (2007) IFN-{gamma}- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 178:7190–7198

    PubMed  CAS  Google Scholar 

  • McPhee JB, Lewenza S, Hancock REW (2003) Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol 50:205–217

    Article  PubMed  CAS  Google Scholar 

  • Miles K, Clarke DJ, Lu W, Sibinska Z, Beaumont PE, Davidson DJ, Barr TA, Campopiano DJ, Gray M (2009) Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J Immunol 183:2122–2132

    Article  PubMed  CAS  Google Scholar 

  • Molhoek EM, den Hertog AL, de Vries AM, Nazmi K, Veerman EC, Hartgers FC, Yazdanbakhsh M, Bikker FJ, van der Kleij D (2009) Structure-function relationship of the human antimicrobial peptide LL-37 and LL-37 fragments in the modulation of TLR responses. Biol Chem 390:295–303

    Article  PubMed  CAS  Google Scholar 

  • Mookherjee N, Brown KL, Bowdish DME, Doria S, Falsafi R, Hokamp K, Roche FM, Mu R, Doho GH, Pistolic J, Powers JP, Bryan J, Brinkman FS, Hancock REW (2006) Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 176:2455–2464

    PubMed  CAS  Google Scholar 

  • Mookherjee N, Lippert DN, Hamill P, Falsafi R, Nijnik A, Kindrachuk J, Pistolic J, Gardy J, Miri P, Naseer M, Foster LJ, Hancock REW (2009) Intracellular receptor for human host defense peptide LL-37 in monocytes. J Immunol 183:2688–2696

    Article  PubMed  CAS  Google Scholar 

  • Morizane S, Yamasaki K, Muhleisen B, Kotol PF, Murakami M, Aoyama Y, Iwatsuki K, Hata T, Gallo RL (2011) Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. J Invest Dermatol 132:135–143

    Article  PubMed  CAS  Google Scholar 

  • Morrison G, Kilanowski F, Davidson DJ, Dorin J (2002) Characterization of the mouse Beta defensin 1, defb1, mutant mouse model. Infect Immun 70:3053–3060

    Article  PubMed  CAS  Google Scholar 

  • Moser C, Weiner DJ, Lysenko E, Bals R, Weiser JN, Wilson JM (2002) beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun 70:3068–3072

    Article  PubMed  CAS  Google Scholar 

  • Murakami M, Lopez-Garcia B, Braff M, Dorschner RA, Gallo RL (2004) Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J Immunol 172:3070–3077

    PubMed  CAS  Google Scholar 

  • Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Heumann D (2001) Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol 167:3329–3338

    PubMed  CAS  Google Scholar 

  • Nagaoka I, Tamura H, Hirata M (2006) An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol 176:3044–3052

    PubMed  CAS  Google Scholar 

  • Nell MJ, Sandra Tjabringa G, Vonk MJ, Hiemstra PS, Grote JJ (2004) Bacterial products increase expression of the human cathelicidin hCAP-18/LL-37 in cultured human sinus epithelial cells. FEMS Immunol Med Microbiol 42:225–231

    Article  PubMed  CAS  Google Scholar 

  • Nell MJ, Tjabringa GS, Wafelman AR, Verrijk R, Hiemstra PS, Drijfhout JW, Grote JJ (2006) Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides 27:649–660

    Article  PubMed  CAS  Google Scholar 

  • Niyonsaba F, Someya A, Hirata M, Ogawa H, Nagaoka I (2001) Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur J Immunol 31:1066–1075

    Article  PubMed  CAS  Google Scholar 

  • Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, Ogawa H, Nagaoka I (2002) A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106:20–26

    Article  PubMed  CAS  Google Scholar 

  • Niyonsaba F, Ushio H, Nagaoka I, Okumura K, Ogawa H (2005) The human {beta}-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J Immunol 175:1776–1784

    PubMed  CAS  Google Scholar 

  • Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454–457

    Article  PubMed  CAS  Google Scholar 

  • Nyberg P, Rasmussen M, Bjorck L (2004) alpha 2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J Biol Chem 279:52820–52823

    Article  PubMed  CAS  Google Scholar 

  • Okumura K, Itoh A, Isogai E, Hirose K, Hosokawa Y, Abiko Y, Shibata T, Hirata M, Isogai H (2004) C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells. Cancer Lett 212:185–194

    Article  PubMed  CAS  Google Scholar 

  • Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151–1160

    Article  PubMed  CAS  Google Scholar 

  • Otte JM, Zdebik AE, Brand S, Chromik AM, Strauss S, Schmitz F, Steinstraesser L, Schmidt WE (2009) Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul Pept 156:104–117

    Article  PubMed  CAS  Google Scholar 

  • Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock RE (2008) The human host defence peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76:4176–4182

    Article  PubMed  CAS  Google Scholar 

  • Park HJ, Cho DH, Kim HJ, Lee JY, Cho BK, Bang SI, Song SY, Yamasaki K, Di Nardo A, Gallo RL (2009) Collagen synthesis is suppressed in dermal fibroblasts by the human antimicrobial peptide LL-37. J Invest Dermatol 129:843–850

    Article  PubMed  CAS  Google Scholar 

  • Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, Hurtado-Ziola N, Nizet V, Johnson RS (2005) HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 115:1806–1815

    Article  PubMed  CAS  Google Scholar 

  • Pier GB, Grout M, Zaidi TS (1997) Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci USA 94:12088–12093

    Article  PubMed  CAS  Google Scholar 

  • Pompilio A, Scocchi M, Pomponio S, Guida F, Di Primio A, Fiscarelli E, Gennaro R, Di Bonaventura G (2011) Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. Peptides 32:1807–1814

    Article  PubMed  CAS  Google Scholar 

  • Putsep K, Carlsson G, Boman HG, Andersson M (2002) Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360:1144–1149

    Article  PubMed  CAS  Google Scholar 

  • Rosenberger CM, Gallo RL, Finlay BB (2004) Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc Natl Acad Sci USA 101:2422–2427

    Article  PubMed  CAS  Google Scholar 

  • Rosenfeld Y, Papo N, Shai Y (2006) Endotoxin (LPS) neutralization by innate immunity host-defense peptides: peptides’ properties and plausible modes of action. J Biol Chem 281:1636–1643

    Article  PubMed  CAS  Google Scholar 

  • Saiman L, Tabibi S, Starner TD, San Gabriel P, Winokur PL, Jia HP, McCray PB Jr, Tack BF (2001) Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother 45:2838–2844

    Article  PubMed  CAS  Google Scholar 

  • Sandgren S, Wittrup A, Cheng F, Jonsson M, Eklund E, Busch S, Belting M (2004) The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J Biol Chem 279:17951–17956

    Article  PubMed  CAS  Google Scholar 

  • Sarker P, Ahmed S, Tiash S, Rekha RS, Stromberg R, Andersson J, Bergman P, Gudmundsson GH, Agerberth B, Raqib R (2011) Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy. PLoS One 6:e20637

    Article  PubMed  CAS  Google Scholar 

  • Savill J, Dransfield I, Gregory C, Haslett C (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2:965–975

    Article  PubMed  CAS  Google Scholar 

  • Schaller-Bals S, Schulze A, Bals R (2002) Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am J Respir Crit Care Med 165:992–995

    PubMed  Google Scholar 

  • Schauber J, Gallo RL (2008) Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 122:261–266

    Article  PubMed  CAS  Google Scholar 

  • Schmidtchen A, Frick IM, Andersson E, Tapper H, Bjorck L (2002) Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 46:157–168

    Article  PubMed  CAS  Google Scholar 

  • Scott MG, Davidson DJ, Gold MR, Bowdish DME, Hancock REW (2002) The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol 169:3883–3891

    PubMed  CAS  Google Scholar 

  • Scott MG, Dullaghan E, Mookherjee N, Glavas N, Waldbrook M, Thompson A, Wang A, Lee K, Doria S, Hamill P, Yu JJ, Li Y, Donini O, Guarna MM, Finlay BB, North JR, Hancock REW (2007) An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol 25:465–472

    Article  PubMed  CAS  Google Scholar 

  • Shaykhiev R, Beisswenger C, Kaendler K, Senske J, Puechner A, Damm T, Behr J, Bals R (2005) The human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 289:L842–L848

    Article  PubMed  CAS  Google Scholar 

  • Soehnlein O, Zernecke A, Eriksson EE, Rothfuchs AG, Pham CT, Herwald H, Bidzhekov K, Rottenberg ME, Weber C, Lindbom L (2008) Neutrophil secretion products pave the way for inflammatory monocytes. Blood 112:1461–1471

    Article  PubMed  CAS  Google Scholar 

  • Soehnlein O, Wantha S, Simsekyilmaz S, Doring Y, Megens RT, Mause SF, Drechsler M, Smeets R, Weinandy S, Schreiber F, Gries T, Jockenhoevel S, Moller M, Vijayan S, van Zandvoort MA, Agerberth B, Pham CT, Gallo RL, Hackeng TM, Liehn EA, Zernecke A, Klee D, Weber C (2011) Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Sci Transl Med 3:103ra98

    Article  PubMed  CAS  Google Scholar 

  • Sonawane A, Santos JC, Mishra B, Jena P, Progida C, Sorensen OE, Gallo R, Appelberg R, Griffiths G (2011) Cathelicidin is involved in the intra-cellular killing of mycobacteria in macrophages. Cell Microbiol 13:1601–1617

    Article  PubMed  CAS  Google Scholar 

  • Sorensen OE, Arnljots K, Cowland JB, Bainton DF, Borregaard N (1997a) The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90:2796–2803

    PubMed  CAS  Google Scholar 

  • Sorensen OE, Cowland JB, Askaa J, Borregaard N (1997b) An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods 206:53–59

    Article  PubMed  CAS  Google Scholar 

  • Sorensen OE, Follin P, Johnsen AH, Calafat J, Tjabringa GS, Hiemstra PS, Borregaard N (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97:3951–3959

    Article  PubMed  CAS  Google Scholar 

  • Sorensen OE, Gram L, Johnsen AH, Andersson E, Bangsboll S, Tjabringa GS, Hiemstra PS, Malm J, Egesten A, Borregaard N (2003) Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina. J Biol Chem 278:28540–28546

    Article  PubMed  CAS  Google Scholar 

  • Subramanian H, Gupta K, Guo Q, Price R, Ali H (2011) MAS-related gene X2 (MrgX2) is a novel G protein coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization and internalization. J Biol Chem 286:44739–44749

    Article  PubMed  CAS  Google Scholar 

  • Tai EK, Wu WK, Wang XJ, Wong HP, Yu L, Li ZJ, Lee CW, Wong CC, Yu J, Sung JJ, Gallo RL, Cho CH (2012) Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp(-/-) mice. Gene Ther. Epub ahead of print

    Google Scholar 

  • Tani K, Murphy WJ, Chertov O, Salcedo R, Koh CY, Utsunomiya I, Funakoshi S, Asai O, Herrmann SH, Wang JM, Kwak LW, Oppenheim JJ (2000) Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int Immunol 12:691–700

    Article  PubMed  CAS  Google Scholar 

  • Taylor K, Barran PE, Dorin JR (2008) Structure-activity relationships in beta-defensin peptides. Biopolymers 90:1–7

    Article  PubMed  CAS  Google Scholar 

  • Termen S, Tollin M, Rodriguez E, Sveinsdottir SH, Johannesson B, Cederlund A, Sjovall J, Agerberth B, Gudmundsson GH (2008) PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells. Mol Immunol 45:3947–3955

    Article  PubMed  CAS  Google Scholar 

  • Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, Borregaard N, Rabe KF, Hiemstra PS (2003) The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 171:6690–6696

    PubMed  CAS  Google Scholar 

  • Tjabringa GS, Ninaber DK, Drijfhout JW, Rabe KF, Hiemstra PS (2006) Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors. Int Arch Allergy Immunol 140:103–112

    Article  PubMed  CAS  Google Scholar 

  • Tokumaru S, Sayama K, Shirakata Y, Komatsuzawa H, Ouhara K, Hanakawa Y, Yahata Y, Dai X, Tohyama M, Nagai H, Yang L, Higashiyama S, Yoshimura A, Sugai M, Hashimoto K (2005) Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol 175:4662–4668

    PubMed  CAS  Google Scholar 

  • Tomasinsig L, Pizzirani C, Skerlavaj B, Pellegatti P, Gulinelli S, Tossi A, Di Virgilio F, Zanetti M (2008) The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. J Biol Chem 283:30471–30481

    Article  PubMed  CAS  Google Scholar 

  • Torchinsky MB, Garaude J, Martin AP, Blander JM (2009) Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 458:78–82

    Article  PubMed  CAS  Google Scholar 

  • Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, McCray PB Jr, Lehrer RI, Welsh MJ, Tack BF (2000) Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 68:2748–2755

    Article  PubMed  CAS  Google Scholar 

  • van der Does AM, Beekhuizen H, Ravensbergen B, Vos T, Ottenhoff TH, van Dissel JT, Drijfhout JW, Hiemstra PS, Nibbering PH (2010) LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature. J Immunol 185:1442–1449

    Article  PubMed  CAS  Google Scholar 

  • von Haussen J, Koczulla R, Shaykhiev R, Herr C, Pinkenburg O, Reimer D, Wiewrodt R, Biesterfeld S, Aigner A, Czubayko F, Bals R (2008) The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. Lung Cancer 59:12–23

    Article  Google Scholar 

  • Wang Y, Agerberth B, Johansson J (1998) Structure and activity of cathelicidin antibacterial proteins. J Protein Chem 17:522–523

    PubMed  CAS  Google Scholar 

  • Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173:2909–2912

    PubMed  CAS  Google Scholar 

  • Weiner DJ, Bucki R, Janmey PA (2003) The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin. Am J Respir Cell Mol Biol 28:738–745

    Article  PubMed  CAS  Google Scholar 

  • Wu WK, Sung JJ, To KF, Yu L, Li HT, Li ZJ, Chu KM, Yu J, Cho CH (2010a) The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells. J Cell Physiol 223:178–186

    PubMed  CAS  Google Scholar 

  • Wu WK, Wang G, Coffelt SB, Betancourt AM, Lee CW, Fan D, Wu K, Yu J, Sung JJ, Cho CH (2010b) Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. Int J Cancer 127:1741–1747

    Article  PubMed  CAS  Google Scholar 

  • Yamasaki K, Schauber J, Coda A, Lin H, Dorschner RA, Schechter NM, Bonnart C, Descargues P, Hovnanian A, Gallo RL (2006) Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J 20:2068–2080

    Article  PubMed  CAS  Google Scholar 

  • Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P, Hovnanian A, Morhenn VB, Gallo RL (2007) Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13:975–980

    Article  PubMed  CAS  Google Scholar 

  • Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192:1069–1074

    Article  PubMed  CAS  Google Scholar 

  • Yu J, Mookherjee N, Wee K, Bowdish DM, Pistolic J, Li Y, Rehaume L, Hancock RE (2007) Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways. J Immunol 179:7684–7691

    PubMed  CAS  Google Scholar 

  • Yu FS, Cornicelli MD, Kovach MA, Newstead MW, Zeng X, Kumar A, Gao N, Yoon SG, Gallo RL, Standiford TJ (2010) Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide. J Immunol 185:1142–1149

    Article  PubMed  CAS  Google Scholar 

  • Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, Kim KK, Lee ZW, Lee SH, Kim JM, Jo EK (2009) Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6:231–243

    Article  PubMed  CAS  Google Scholar 

  • Zaiou M, Nizet V, Gallo RL (2003) Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol 120:810–816

    Article  PubMed  CAS  Google Scholar 

  • Zanetti M (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75:39–48

    Article  PubMed  CAS  Google Scholar 

  • Zhang Z, Cherryholmes G, Shively JE (2008) Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin. J Leukoc Biol 84:780–788

    Article  PubMed  CAS  Google Scholar 

  • Zhang Z, Cherryholmes G, Chang F, Rose DM, Schraufstatter I, Shively JE (2009) Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils. Eur J Immunol 39:3181–3194

    Article  PubMed  CAS  Google Scholar 

  • Zhang X, Oglecka K, Sandgren S, Belting M, Esbjorner-Winters EK, Norden B, Graslund A (2010) Dual functions of the human antimicrobial peptide LL-37-Target membrane perturbation and host cell cargo delivery. Biochim Biophys Acta 1798:2201–2208

    Article  PubMed  CAS  Google Scholar 

  • Zheng Y, Niyonsaba F, Ushio H, Nagaoka I, Ikeda S, Okumura K, Ogawa H (2007) Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils. Br J Dermatol 157:1124–1131

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The University of Edinburgh is a charitable body, registered in Scotland, with registration number SC005336.

Author information

Authors and Affiliations

  1. University of Edinburgh/MRC Centre for Inflammation Research, Queen’s Medical Research Institute, W2.05, 47 Little France Crescent, Edinburgh, EH16 4TJ, Scotland, UK

    Paula E. Beaumont, Hsin-Ni Li & Donald J. Davidson

Authors
  1. Paula E. Beaumont
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hsin-Ni Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Donald J. Davidson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Donald J. Davidson .

Editor information

Editors and Affiliations

  1. , Department of Pulmonology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2300 RC, Netherlands

    Pieter S. Hiemstra

  2. Ctr for Infection & Immun. Amsterdam, Dept. Medical Microbiology, University of Amsterdam, Meibergdreef 15, Amsterdam, 1105 AZ, Netherlands

    Sebastian A. J. Zaat

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Basel AG

About this chapter

Cite this chapter

Beaumont, P.E., Li, HN., Davidson, D.J. (2013). LL-37: An Immunomodulatory Antimicrobial Host Defence Peptide. In: Hiemstra, P., Zaat, S. (eds) Antimicrobial Peptides and Innate Immunity. Progress in Inflammation Research. Springer, Basel. https://doi.org/10.1007/978-3-0348-0541-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-0541-4_4

  • Published:

  • Publisher Name: Springer, Basel

  • Print ISBN: 978-3-0348-0540-7

  • Online ISBN: 978-3-0348-0541-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation